Early and strong antibody responses to SARS-CoV-2 predict disease severity in COVID-19 patients

BACKGROUND: Antibody response to SARS-CoV-2 is a valuable biomarker for the assessment of the spread of the virus in a population and evaluation of the vaccine candidates. Recent data suggest that antibody levels also may have a prognostic significance in COVID-19. Most of the serological studies so...

Descripción completa

Detalles Bibliográficos
Autores principales: Plūme, Jānis, Galvanovskis, Artis, Šmite, Sindija, Romanchikova, Nadezhda, Zayakin, Pawel, Linē, Aija
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012069/
https://www.ncbi.nlm.nih.gov/pubmed/35428263
http://dx.doi.org/10.1186/s12967-022-03382-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012069/
https://www.ncbi.nlm.nih.gov/pubmed/35428263
http://dx.doi.org/10.1186/s12967-022-03382-y

Ejemplares similares